US Equity
ANAB
— ANAPTYSBIO, INC.AnaptysBio, Inc. is a clinical-stage biotechnology company that develops antibody-based therapeutics for inflammation and immune-mediated diseases.
💰 Market cap: $1.59B📍 10770 Wateridge Circle, Suite 210, SAN DIEGO, CA, 92121 US🏷️ Biotechnology & Medical Research💵 Previous close: $54.15🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $54.15 |
| 2026-07-23 | $54.91 |
| 2026-07-22 | $52.61 |
| 2026-07-21 | $53.76 |
| 2026-07-20 | $50.29 |
| 2026-07-17 | $58.00 |
| 2026-07-16 | $54.15 |
| 2026-07-15 | $55.82 |
| 2026-07-14 | $62.51 |
| 2026-07-13 | $69.81 |
| 2026-07-10 | $66.39 |
| 2026-07-09 | $66.59 |
| 2026-07-08 | $65.35 |
| 2026-07-07 | $67.33 |
| 2026-07-06 | $62.31 |
| 2026-07-02 | $63.42 |
| 2026-07-01 | $65.43 |
| 2026-06-30 | $67.50 |
| 2026-06-29 | $65.97 |
| 2026-06-26 | $63.15 |
| 2026-06-25 | $59.68 |
| 2026-06-24 | $58.48 |
| 2026-06-23 | $59.43 |
| 2026-06-22 | $59.99 |
| 2026-06-18 | $57.51 |
| 2026-06-17 | $56.77 |
| 2026-06-16 | $57.61 |
| 2026-06-15 | $59.51 |
| 2026-06-12 | $56.07 |
| 2026-06-11 | $54.24 |
| 2026-06-10 | $52.10 |
| 2026-06-09 | $51.63 |
| 2026-06-08 | $51.36 |
| 2026-06-05 | $50.37 |
| 2026-06-04 | $51.67 |
| 2026-06-03 | $51.24 |
| 2026-06-02 | $51.26 |
| 2026-06-01 | $53.14 |
| 2026-05-29 | $55.67 |
| 2026-05-28 | $57.02 |
| 2026-05-27 | $57.69 |
| 2026-05-26 | $57.77 |
| 2026-05-22 | $59.71 |
| 2026-05-21 | $60.41 |
| 2026-05-20 | $60.08 |
| 2026-05-19 | $59.77 |
| 2026-05-18 | $58.74 |
| 2026-05-15 | $63.15 |
| 2026-05-14 | $62.19 |
| 2026-05-13 | $62.69 |
| 2026-05-12 | $65.58 |
| 2026-05-11 | $67.92 |
| 2026-05-08 | $69.33 |
| 2026-05-07 | $66.96 |
| 2026-05-06 | $67.36 |
| 2026-05-05 | $69.28 |
| 2026-05-04 | $69.78 |
| 2026-05-01 | $66.76 |
| 2026-04-30 | $65.73 |
| 2026-04-29 | $62.34 |
| 2026-04-28 | $66.11 |